[Treatment of venous thromboembolism]

Med Clin (Barc). 2000 Jul 8;115(6):224-35. doi: 10.1016/s0025-7753(00)71516-8.
[Article in Spanish]
No abstract available

Publication types

  • Comparative Study
  • Review

MeSH terms

  • Administration, Oral
  • Adult
  • Anticoagulants / administration & dosage
  • Anticoagulants / therapeutic use
  • Enoxaparin / administration & dosage
  • Enoxaparin / therapeutic use
  • Female
  • Fibrinolytic Agents / administration & dosage
  • Fibrinolytic Agents / therapeutic use
  • Heparin / administration & dosage
  • Heparin / therapeutic use
  • Heparin, Low-Molecular-Weight / administration & dosage
  • Heparin, Low-Molecular-Weight / therapeutic use
  • Humans
  • Male
  • Meta-Analysis as Topic
  • Pregnancy
  • Pregnancy Complications, Cardiovascular / drug therapy
  • Randomized Controlled Trials as Topic
  • Risk
  • Thrombectomy
  • Thromboembolism / drug therapy
  • Thromboembolism / mortality
  • Thromboembolism / surgery
  • Thromboembolism / therapy*
  • Thrombolytic Therapy
  • Time Factors
  • Vena Cava Filters
  • Venous Thrombosis / drug therapy
  • Venous Thrombosis / mortality
  • Venous Thrombosis / surgery
  • Venous Thrombosis / therapy*
  • Warfarin / administration & dosage
  • Warfarin / therapeutic use

Substances

  • Anticoagulants
  • Enoxaparin
  • Fibrinolytic Agents
  • Heparin, Low-Molecular-Weight
  • Warfarin
  • Heparin